Literature DB >> 15249208

CpG oligodeoxynucleotides directly induce CXCR3 chemokines in human B cells.

Atsushi Kato1, Takahisa Ogasawara, Toshiki Homma, Jonathan Batchelor, Shosuke Imai, Hiroshi Wakiguchi, Hirohisa Saito, Kenji Matsumoto.   

Abstract

CpG oligodeoxynucleotides (CpG ODN) are known to elicit Th1 immune responses via TLR9. However, the precise mechanisms through which B cells are involved in this phenomenon are not fully understood. We investigated the effect of CpG ODN on the induction of Th1-chemoattractant CXCR3 chemokines, IP-10, Mig, and I-TAC, in B cells. Cells from the RPMI 8226 human B cell line and human peripheral B cells were stimulated with three distinct classes of CpG ODN. As a result, CXCR3 chemokines were strongly up-regulated by CpG-B and CpG-C, but only weakly by CpG-A. Though CXCR3 chemokines are known to be induced by IFNs, blocking mAbs against IFN receptors did not inhibit their induction by CpG-B. Induction of CXCR3 chemokines was blocked by two NF-kappaB inhibitors and a p38 inhibitor. These results strongly suggest that CXCR3 chemokines are directly induced by CpG ODN via NF-kappaB- and p38-dependent pathways in human B cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249208     DOI: 10.1016/j.bbrc.2004.06.059

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  CpG DNA as a vaccine adjuvant.

Authors:  Christian Bode; Gan Zhao; Folkert Steinhagen; Takeshi Kinjo; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

2.  CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.

Authors:  Makoto Ishii; Cory M Hogaboam; Amrita Joshi; Toshihiro Ito; Daniel J Fong; Steven L Kunkel
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

3.  Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway.

Authors:  Katharine E Black; Samuel L Collins; Robert S Hagan; Mark J Hamblin; Yee Chan-Li; Robert W Hallowell; Jonathan D Powell; Maureen R Horton
Journal:  J Inflamm (Lond)       Date:  2013-05-30       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.